Circulating Hsp70 Levels and the Immunophenotype of Peripheral Blood Lymphocytes as Potential Biomarkers for Advanced Lung Cancer and Therapy Failure after Surgery

Lung cancer remains a devastating disease with a poor clinical outcome. A biomarker signature which could distinguish lung cancer from metastatic disease and detect therapeutic failure would significantly improve patient management and allow for individualized, risk-adjusted therapeutic decisions. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Safi, Seyer, Messner, Luis, Kliebisch, Merten, Eggert, Linn, Ceylangil, Ceyra, Lennartz, Philipp, Jefferies, Benedict, Klein, Henriette, Schirren, Moritz, Dommasch, Michael, Lobinger, Dominik, Multhoff, Gabriele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216400/
https://www.ncbi.nlm.nih.gov/pubmed/37238744
http://dx.doi.org/10.3390/biom13050874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10216400/
https://www.ncbi.nlm.nih.gov/pubmed/37238744
http://dx.doi.org/10.3390/biom13050874

Ejemplares similares